Advertisement

Topics

Latest "Criticality Experiments Enhance Nuclear Safety Security Effectiveness" News Stories

01:30 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "Criticality Experiments Enhance Nuclear Safety Security Effectiveness" found in our extensive news archives from over 250 global news sources.

More Information about Criticality Experiments Enhance Nuclear Safety Security Effectiveness on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Criticality Experiments Enhance Nuclear Safety Security Effectiveness for you to read. Along with our medical data and news we also list Criticality Experiments Enhance Nuclear Safety Security Effectiveness Clinical Trials, which are updated daily. BioPortfolio also has a large database of Criticality Experiments Enhance Nuclear Safety Security Effectiveness Companies for you to search.

Showing "Criticality Experiments Enhance Nuclear Safety Security Effectiveness" News Articles 1–25 of 9,100+

Friday 22nd February 2019

Opinion: The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews. https://buff.ly/2IugS1y 

Opinion: The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews. https://buff.ly/2IugS1y 


FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns

A Karyopharm Therapeutics multiple myeloma drug candidate faces longer odds for speedy FDA approval after the agency’s staff raised questions about the therapy’s efficacy and safety. Staff concerns about Karyopharm drug selinexor were detailed in briefing documents posted Friday afternoon, ahead of an advisory committee meeting scheduled for Tuesday. Such panels are convened to assess […...

MSA Safety Inc. (MSA) CEO Nish Vartanian on Q4 2018 Results - Earnings Call Transcript


Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene

Schedules April 12, 2019 Special Meeting of Stockholders to Vote on Transaction Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Celgene Corporation (NASDAQ:CELG). Bristol-Myers Squibb will commence...

Look at the facts. Drug importation is dangerous.

Today, 1 in 10 medicines worldwide and up to 50 percent of drugs consumed in developing nations are counterfeit. Importation proposals would open the U.S. borders to these dangerous and potentially deadly substances. We support efforts to ensure patients have access to the medicines they need, but importation schemes have not

Texas & New Mexico Hospice Organization and Accreditation Commission for Health Care Form Partnership

Accreditation Commission for Health Care is excited to announce its new partnership with Texas & New Mexico Hospice Organization. This agreement allows TNMHO members to receive special pricing on ACHC’s Hospice Accreditation services, as well as discounts on ACHCU educational resources that help prepare association members for ACHC Accreditation. CARY, N.C. (PRWEB) February 22, 2019 Accredi...

FDA: Gout Drug Uloric Increases Risk of Death

FRIDAY, Feb. 22, 2019 -- The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration. The agency said its in-depth review of results from a safety clinical trial found...

Cardinal Park Family Dental Care Offers Leesburg, Virginia Full Arch Dental Implants for Lasting, Functional Smiles

Trusted dentists at Cardinal Park Family Dental Care, Drs. Gary Ashton, Hugo Manrique, Christine Han and Nassir Barekzi, invite new and existing patients to receive a consultation for full arch dental implants in Leesburg with or without a referral. Leesburg, VA (PRWEB) February 22, 2019 Respected dentists, Drs. Gary Ashton, Hugo Manrique, Christine Han and Nassir Barekzi welcome new and existing...

Phibro Introduces Poultry Innovations at IPPE

Phivax™ ChickPak and Provia™ Prime help poultry producers ensure a healthy start and healthy life Several new poultry health innovations will help to ensure a healthy start and healthier life for birds with an added benefit of reducing the need for antibiotics. Phibro Animal Health Corporation introduced the products at the 2019 International Produ...

The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy

Healthcare Analytics: Lowering Cost of Care and Enhancing Patient Satisfaction | Quantzig

Quantzig, a leading analytics advisory firm that delivers customized analytics solutions, has announced the completion of their article on the role of healthcare analytics in improving healthcare operations globally. This article highlights the impact that

Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance i...

AchievaMed Leads Charge to Provide Exclusively Domestic MSO Services

With health plans facing increased scrutiny for utilizing offshore resources, Managed Service Organizations will struggle to pivot and meet compliance requirements AchievaMed, a leading Managed Services Organization (MSO), is standing firm in their commitment to employing domestic talent in servicing their growing portfolio of medical group and health ...

FDA Plans to Tighten Sunscreen Safety Regulations

(MedPage Today) -- New proposal calls for improved broad spectrum and UVA protection

Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

NOVATO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced positive longer-term top-line safety and efficacy data from the first, lowest dose cohort of the ongoing Phase 1/2 study of DTX401, an adeno-associated …

Opinion: What's a year of life worth? The QALY aims to answer that question with a subjective price tag. It shouldn't be the main metric for guiding drug cost-effectiveness reviews. https://buff.ly/2GF3mWO 

Opinion: What's a year of life worth? The QALY aims to answer that question with a subjective price tag. It shouldn't be the main metric for guiding drug cost-effectiveness reviews. https://buff.ly/2GF3mWO 

Viewpoints: Saving Rural Hospitals Can Save More Than Lives; Listen To Evidence About Gun Safety And Children, Not The NRA

Opinion writers weigh in on these health topics and others.

Cerus to Participate In Upcoming Investor Conferences

Cerus Corporation (Nasdaq:CERS) announced today that the Company will participate in two upcoming investor conferences. Obi Greenman, Cerus’ president and chief executive officer is scheduled to attend BTIG’s Annual Healthcare Conference in Snowbird Utah on Wednesday, February 27, 2019. Obi Greenman and Kevin Green,...

Mabel's Labels Launches Brand New Website

New MabelsLabels.com Features Mobile Optimization, Streamlined E-Commerce Functionality, & An Intuitive, User-Friendly Experience HAMILTON, Ontario (PRWEB) February 22, 2019 Mabel's Labels the award-winning market leader for labels for the stuff kids lose®, announced the launch of its new website, MabelsLabels.com. The new site, which went live on February 19th, features a modern and...

$ARAY Ph3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer https://www.prnewswire.com/news-releases/phase-3-randomized-trial-data-shows-sbrt-has-similar-acute-sa

$ARAY Ph3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer https://www.prnewswire.com/news-releases/phase-3-randomized-trial-data-shows-sbrt-has-similar-acute-safety-profile-to-conventional-radiation-therapy-in-patients-with-localized-prostate-cancer-300800156.html …

Achieve Life Sciences shares rocket after promising smoking-cessation drug trial

The trial evaluated the effectiveness of the drug cytisinicline on smoking cessation

Opinion: Even as we think of new ways to enhance the upbringing of our children, we should hold to some old ways and do what we can to keep alive the grandmother effect. https://buff.ly/2GELRGs 

Opinion: Even as we think of new ways to enhance the upbringing of our children, we should hold to some old ways and do what we can to keep alive the grandmother effect. https://buff.ly/2GELRGs 

Antibe Therapeutics Recognized as a 2019 TSX Venture 50 Company

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, is pleased to announce that it has been named a 2019 TSX Venture 50™ company, an award that recognizes the top performing companies on the TSX Venture Exchange over the past year. Antibe was ra...

Gossamer Bio Announces Participation in Upcoming Investor Conferences

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that Sheila Gujrathi, M.D., Chief Executive Officer and Co-Founder, will present at the following upcoming investor c...

Postlicensure Safety Surveillance of Shingrix

Are early safety monitoring findings for recombinant zoster vaccine (Shingrix) consistent with prelicensure clinical trial data? Morbidity & Mortality Weekly Report


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks